Quality Means Business (QMB), an emerging leader in AI-driven MedTech SaaS, has closed a $2M seed round to launch QualiVerse, a Regulatory Intelligence Engine that helps medical device innovators achieve compliance, accelerate new product development, and scale safely to market. The round, led by The Boston Foundation's Business Equity Investment Fund and CEI Ventures, positions QMB as a category-defining company at the intersection of AI, regulatory intelligence, and MedTech innovation.